CervoMed CRVO
NASDAQ CRVO
$1.77 +0.40 (+29.20%)
At close: Nov 11, 2026 · 4:00 PM EST

CervoMed (CRVO) Restructuring Costs (2015)

Updated

CervoMed's Restructuring Costs was $967,683 in FY2015.

Analysis

CervoMed (CRVO) Restructuring Costs (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CervoMed 20.73 Mn -57.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 967,683.00
API Access

CervoMed Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CRVO&period=max&api_key=YOUR_API_KEY